By binding to these receptors, the medication helps you feel full longer and slows down gastric emptying, which is the process of food leaving your stomach
Moreover, IGF-1 can regulate the cell differentiation by activating the downstream signaling pathways through its receptor IGF-1R, and IGF-1/IGF-1R pathway is thereby known as IGF-1/IGF-1R axis
Tirzepatide has not been compared directly with other weight-loss medications
Tirzepatide targets two receptors (GLP-1 and GIP)
Intense Exercise High-intensity interval training (HIIT) and resistance training trigger GH release, especially when combined with fasting
AHI reduction: Tirzepatide 15mg reduced apnea-hypopnea events by approximately 25-30 per hour vs 5 per hour for placebo Responder rate: Around 42% of tirzepatide participants achieved complete or near-complete resolution of sleep apnea events Weight loss: Average 18% body weight reduction accompanied the AHI improvements, consistent with SURMOUNT-1 data at comparable doses Source: Malhotra et al., NEJM 2024 Sleep Apnea Dosing vs Weight Loss Dosing The titration schedule is the same for both indications